BridgeMD
New treatment option for Breast Cancer
Official title Evaluation of Improvements in Patient-reported Quality of Life
ClinicalTrials.gov ID: NCT06002022
What this study is testing
- What it's testing
- Local intervention trial for the evaluation of improvements in patient-reported Quality of Life and treatment satisfaction, in breast cancer patients (BCP), as a result of flexible treatment planning supported by REBECCA-collected real-world data, in comparison with standard care
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75, women only
You may be able to join if
- Before patient registration, written informed consent must be given according to national and local regulations.
- Participants have had histologically proven stage I-III breast cancer undergoing endocrine treatment (with or without prior chemotherapy) no more...
- Be between 18 and 75 years of age.
- Have increased life expectancy beyond the initial 3 months post-treatment initiation.
- Have the ability to understand protocol, participate in testing and willingness to sign a written informed consent.
You likely can't join if
- Patients that are not willing to sign an informed consent form
See the full eligibility criteria
- Before patient registration, written informed consent must be given according to national and local regulations.
- Participants have had histologically proven stage I-III breast cancer undergoing endocrine treatment (with or without prior chemotherapy) no more than 12 months prior to randomization.
- Be between 18 and 75 years of age.
- Have increased life expectancy beyond the initial 3 months post-treatment initiation.
- Have the ability to understand protocol, participate in testing and willingness to sign a written informed consent.
- Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.
- Patients that are not willing to sign an informed consent form
The study team makes the final eligibility decision.
Where it's taking place
- Valencia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valencia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.